Download FIRST fully implantable pacemaker FIRST

1958
2013
First self-contained leadless pacemaker
Nanostim pacemaker is the world’s first commercialized
leadless pacemaker (2g 1cc) that resides entirely in the
right ventricle of the heart and is introduced through a
small puncture in the groin avoiding leads in the vascular
system and the need for a surgical pocket.
FIRST fully implantable pacemaker
1981
FIRST microprocessor-based pacemaker
The Tachylog™ device was a tachycardia terminating
pulse generator controlled by a microprocessor that
offered four programmable tachy terminating programs.
Adopting computer technologies to accommodate
increased capabilities significantly enhanced a
physician’s ability to adjust pacemaker settings and
obtain diagnostic information.
Arne Larsson became the first person to receive a
fully implantable pacemaker in a groundbreaking
operation in Stockholm, Sweden. Mr. Larsson went
on to enjoy a full, active life until his death in 2001
at age 86. At the time of his death, he had received
22 pacemakers over a period of 43 years. His death
was unrelated to any cardiac or device problem.
1995
FIRST Sub 14 gram pacemaker in the world
The Microny™ pacemaker was the world’s smallest
pacing device, weighing approximately 14 grams and
roughly the size of a half-dollar.
2009
FIRST pacemaker with RF telemetry from
implant through follow-up
Since the first implantable pacemaker was developed in 1958, millions have benefited from pacemaker
therapy. The remarkable story of the first cardiac pacemaker is embedded in St. Jude Medical’s history, and
today, St. Jude Medical is once again demonstrating its commitment to revolutionizing the cardiac rhythm
management space with the introduction of the world’s first commercially available leadless pacemaker.
The Nanostim™ leadless pacemaker is one-tenth the size of a conventional pacemaker and is considered
one of the most significant advances in the history of pacemaker technology. The device recently received
CE Mark approval and is now available in select European markets. It also recently received U.S. Food and
Drug Administration (FDA) conditional approval for its Investigational Device Exemption (IDE) application
and pivotal clinical trial protocol to begin evaluating Nanostim leadless technology in the U.S.
Caution: Investigational Device Limited by Federal (or United States) Law to Investigational Use. Not Approved for Sale in the U.S.
Unless otherwise noted, ™ indicates that the name is a trademark of, or licensed to, St. Jude Medical or one of its subsidiaries. ST. JUDE MEDICAL and
the nine-squares symbol are trademarks and service marks of St. Jude Medical, Inc. and its related companies. © 2013 St. Jude Medical, Inc. All Rights Reserved.
The Accent™ RF pacemaker and Anthem™ RF
CRT-P (cardiac resynchronization therapy pacemaker)
feature RF telemetry that enables secure, wireless
communication between the implanted device and
the programmer used by the clinician or a home
monitor, making it the first integrated system of
pacing devices with wireless telemetry from implant
through follow-up.
FIRST device with AutoCapture™
pacing system
The AutoCapture pacing system was the first algorithm
designed for pacemakers to monitor ventricular capture
on every beat of the heart, and then deliver the
minimum amount of energy required for pacing.